$1.84 Billion is the total value of Alphabet Inc.'s 65 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 15.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DXCM | Buy | Dexcom Inc | $312,143,000 | -41.9% | 4,188,154 | +298.6% | 16.94% | -2.9% |
| PATH | UiPath Inccl a | $255,910,000 | -15.7% | 14,068,674 | 0.0% | 13.89% | +40.9% | |
| EQRX Inc | $223,022,000 | +13.6% | 47,552,687 | 0.0% | 12.10% | +90.0% | ||
| VERV | Verve Therapeutics Inc | $167,683,000 | -33.0% | 10,974,011 | 0.0% | 9.10% | +12.0% | |
| Planet Labs PBC | $138,312,000 | -14.8% | 31,942,641 | 0.0% | 7.51% | +42.6% | ||
| OSCR | Oscar Health Inccl a | $102,181,000 | -57.4% | 24,042,864 | 0.0% | 5.55% | -28.7% | |
| LYFT | Lyft Inc | $81,515,000 | -65.4% | 6,138,154 | 0.0% | 4.42% | -42.2% | |
| SNOW | Snowflake Inccl a | $74,481,000 | -39.3% | 535,604 | 0.0% | 4.04% | +1.5% | |
| Freshworks Inc | $53,068,000 | -26.6% | 4,035,595 | 0.0% | 2.88% | +22.8% | ||
| Benson Hill Inc | $42,065,000 | -15.2% | 15,352,271 | 0.0% | 2.28% | +41.9% | ||
| Robinhood Mkts Inc | $40,513,000 | -39.2% | 4,928,535 | 0.0% | 2.20% | +1.8% | ||
| LYEL | Lyell Immunopharma Inc | $38,241,000 | +29.1% | 5,865,125 | 0.0% | 2.08% | +116.0% | |
| New | Gitlab Inc | $31,533,000 | – | 593,404 | +100.0% | 1.71% | – | |
| RLAY | Relay Therapeutics Inc | $26,277,000 | -44.0% | 1,568,753 | 0.0% | 1.43% | -6.4% | |
| DM | Desktop Metal Inc | $24,307,000 | -53.6% | 11,048,730 | 0.0% | 1.32% | -22.4% | |
| Adagio Therapeutics Inc | $18,633,000 | -28.1% | 5,680,785 | 0.0% | 1.01% | +20.4% | ||
| Toast Inccl a | $18,539,000 | -40.5% | 1,432,660 | 0.0% | 1.01% | -0.4% | ||
| SANA | Sana Biotechnology Inc | $18,084,000 | -22.2% | 2,812,500 | 0.0% | 0.98% | +30.1% | |
| ME | 23andMe Holding Co | $16,707,000 | -35.2% | 6,736,785 | 0.0% | 0.91% | +8.4% | |
| GLUE | Monte Rosa Therapeutics Inc | $14,157,000 | -31.0% | 1,464,015 | 0.0% | 0.77% | +15.3% | |
| Duolingo Inc. | $12,646,000 | -7.9% | 144,444 | 0.0% | 0.69% | +53.8% | ||
| BEAM | Beam Therapeutics Inc | $12,449,000 | -32.4% | 321,604 | 0.0% | 0.68% | +13.0% | |
| IDYA | Ideaya Biosciences Inc | $10,394,000 | +23.3% | 753,187 | 0.0% | 0.56% | +106.6% | |
| ILMN | Illumina Inc | $9,858,000 | -47.2% | 53,470 | 0.0% | 0.54% | -11.7% | |
| RAPT | RAPT Therapeutics Inc | $9,860,000 | -17.0% | 540,270 | 0.0% | 0.54% | +39.0% | |
| New | Velo3d Inc | $7,399,000 | – | 5,361,671 | +100.0% | 0.40% | – | |
| Rani Therapeutics Hldgs Inc | $7,380,000 | -23.5% | 714,471 | 0.0% | 0.40% | +28.1% | ||
| DBTX | Decibel Therapeutics Inc | $6,889,000 | +38.5% | 1,636,258 | 0.0% | 0.37% | +132.3% | |
| FHTX | Foghorn Therapeutics Inc | $6,812,000 | -10.7% | 500,901 | 0.0% | 0.37% | +49.2% | |
| VACC | Vaccitech PLCads | $6,736,000 | -14.4% | 1,513,644 | 0.0% | 0.37% | +43.5% | |
| Sell | Science 37 Holdings Inc | $6,447,000 | -62.8% | 3,207,260 | -1.0% | 0.35% | -37.8% | |
| KRON | Kronos Bio Inc | $5,235,000 | -49.7% | 1,438,232 | 0.0% | 0.28% | -15.7% | |
| Tenaya Therapeutics Inc | $5,155,000 | -52.2% | 915,705 | 0.0% | 0.28% | -20.0% | ||
| NEWR | New Relic Inc | $4,561,000 | -25.2% | 91,132 | 0.0% | 0.25% | +25.3% | |
| VERA | Vera Therapeutics Inccl a | $4,105,000 | -42.1% | 301,580 | 0.0% | 0.22% | -3.0% | |
| MGTA | Magenta Therapeutics Inc | $4,007,000 | -58.6% | 3,339,138 | 0.0% | 0.22% | -30.9% | |
| Tscan Therapeutics Inc | $3,387,000 | +12.3% | 1,077,080 | 0.0% | 0.18% | +87.8% | ||
| Amplitude Inc | $2,707,000 | -22.5% | 189,447 | 0.0% | 0.15% | +30.1% | ||
| TSHA | Taysha Gene Therapies Inc | $2,384,000 | -43.0% | 640,882 | 0.0% | 0.13% | -5.1% | |
| OMIC | Singular Genomics Systems Inc | $2,241,000 | -39.4% | 586,584 | 0.0% | 0.12% | +1.7% | |
| EVLO | Evelo Biosciences Inc | $2,238,000 | -37.7% | 1,060,495 | 0.0% | 0.12% | +3.4% | |
| Hyperfine Inc | $2,004,000 | -37.0% | 898,720 | 0.0% | 0.11% | +5.8% | ||
| AUTL | Autolus Therapeutics PLCspon adr | $1,976,000 | -32.1% | 698,262 | 0.0% | 0.11% | +13.8% | |
| ALEC | Alector Inc | $1,787,000 | -28.7% | 175,866 | 0.0% | 0.10% | +19.8% | |
| FULC | Fulcrum Therapeutics Inc | $1,252,000 | -79.3% | 255,452 | 0.0% | 0.07% | -65.3% | |
| Enjoy Technology Inc | $943,000 | -94.3% | 4,345,340 | 0.0% | 0.05% | -90.5% | ||
| EXAS | Exact Sciences Corp | $914,000 | -43.6% | 23,205 | 0.0% | 0.05% | -5.7% | |
| OPRT | Oportun Finl Corp | $784,000 | -42.4% | 94,788 | 0.0% | 0.04% | -2.3% | |
| SPRO | Spero Therapeutics Inc | $659,000 | -91.5% | 889,979 | 0.0% | 0.04% | -85.7% | |
| NVTA | Invitae Corp | $527,000 | -69.4% | 215,965 | 0.0% | 0.03% | -48.2% | |
| S | Sentinelone Inccl a | $495,000 | -39.8% | 21,231 | 0.0% | 0.03% | 0.0% | |
| CRTX | Cortexyme Inc | $420,000 | -64.1% | 189,122 | 0.0% | 0.02% | -39.5% | |
| WeWork Inccl a | $319,000 | -26.5% | 63,645 | 0.0% | 0.02% | +21.4% | ||
| Cue Health Inc | $86,000 | -50.6% | 27,000 | 0.0% | 0.01% | -16.7% | ||
| RGEN | Repligen Corp | $62,000 | -13.9% | 383 | 0.0% | 0.00% | +50.0% | |
| SPGI | Exit | S&P Global Inc | $0 | – | -592 | -100.0% | -0.01% | – |
| CMPX | Exit | Compass Therapeutics Inc | $0 | – | -192,794 | -100.0% | -0.01% | – |
| SQZ | Exit | SQZ Biotechnologies Co | $0 | – | -103,929 | -100.0% | -0.02% | – |
| Exit | Nextdoor Holdings Inc | $0 | – | -97,391 | -100.0% | -0.02% | – | |
| TWLO | Exit | Twilio Inccl a | $0 | – | -3,710 | -100.0% | -0.02% | – |
| RCUS | Exit | Arcus Biosciences Inc | $0 | – | -2,563,441 | -100.0% | -2.62% | – |
| Exit | IonQ Inc | $0 | – | -21,907,038 | -100.0% | -9.07% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 10-Q | 2024-04-26 |
| 144 | 2024-04-26 |
| 4 | 2024-04-26 |
| 4 | 2024-04-26 |
| ARS | 2024-04-26 |
| DEF 14A | 2024-04-26 |
| DEFA14A | 2024-04-26 |
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.